Feb 27, 2017

London Stock Exchange says Deutsche Boerse merger is basically dead

Sang Tan / AP

The London Stock Exchange Group said late Sunday that its $30 billion merger with Deutsche Boerse is unlikely to receive approval from European regulators.

The deal — which would have combined stock exchanges in Britain, Germany, and Italy, as well as several of Europe's largest clearinghouses — fell apart when European Commission regulators told LSE that it would need to divest MTS, an electronic platform for trading government bonds and other fixed income products. LSE believes the condition is "disproportionate," and therefore believes the broader merger is dead.

Background: The exchanges agreed to the merger last March, and shareholders approved the deal in July. But, in September, European antitrust regulators opened an investigation. This had been the two exchanges' third attempt to come together since 2000.

Go deeper

The global scramble to contain the coronavirus

Taking precaution, in the Philippines. Photo: Ezra Acayan/Getty Images

The coronavirus is spreading quickly in cities nowhere near Wuhan, China, and the window to prevent a global pandemic is narrowing.

Zoom in: Here's a look at what comes with a coronavirus outbreak in communities outside China that have been hardest hit so far.

Go deeperArrow2 mins ago - World

Experimental coronavirus vaccine to be tested on humans

Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases. Photo: Win McNamee/Getty Images

The vaccine that the National Institute of Allergy and Infectious Diseases (NIAID) and drugmaker Moderna have been developing to combat the coronavirus is ready to be tested on humans, NIAID director Anthony Fauci told the Wall Street Journal.

The state of play: The rapidly developed vaccine will be tested on 20–25 healthy volunteers in April to determine whether two doses will be safe and generate an immune response to protect against infection. Results will be available in July or August, Fauci told WSJ.